TA
RPRX

Teachers Advisors’s Repros Therapeutics Inc. RPRX Stock Holding History

Teachers Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-38,143
Closed -$328K – 3255
2015
Q1 		$328K Buy
38,143
+5,453
+17% +$48.8K ﹤0.01% 2675
2014
Q4 		$326K Sell
32,690
-4,749
-13% -$40.5K ﹤0.01% 2675
2014
Q3 		$371K Buy
37,439
+5,394
+17% +$79.9K ﹤0.01% 2559
2014
Q2 		$554K Sell
32,045
-2,147
-6% -$35K ﹤0.01% 2374
2014
Q1 		$607K Hold
34,192
– – ﹤0.01% 2304
2013
Q4 		$626K Buy
34,192
+2,940
+9% +$55.5K ﹤0.01% 2262
2013
Q3 		$838K Buy
31,252
+5,216
+20% +$112K ﹤0.01% 2023
2013
Q2 		$480K Buy
+26,036
New +$460K ﹤0.01% 2262

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return

Teachers Advisors's RPRX Position: Q2 2015 in Review

Teachers Advisors sold out of Repros Therapeutics Inc. (RPRX) in Q2 2015, closing a stake of 38,143 shares — an estimated $328K sold.

Teachers Advisors first reported a position in RPRX in Q2 2013 and held it in 8 quarters. The position peaked at $838K in Q3 2013. 64 funds tracked by Wall St. Rank hold RPRX as of Q2 2015.

  • Teachers Advisors reported no remaining Repros Therapeutics Inc. position as of Q2 2015 after selling out during the quarter.
  • Teachers Advisors sold 38,143 Repros Therapeutics Inc. shares in Q2 2015, an estimated $328K.
  • Teachers Advisors first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 8 quarters.
  • Teachers Advisors's Repros Therapeutics Inc. position peaked at $838K in Q3 2013.
  • 64 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2015.

Based on Teachers Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.